Your browser doesn't support javascript.
loading
Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
Mahadevan, Uma; McConnell, Ryan A; Chambers, Christina D.
Affiliation
  • Mahadevan U; Department of Medicine, Division of Gastroenterology, University of California, San Francisco, San Francisco, California. Electronic address: uma.mahadevan@ucsf.edu.
  • McConnell RA; Department of Medicine, Division of Gastroenterology, University of California, San Francisco, San Francisco, California.
  • Chambers CD; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California.
Gastroenterology ; 152(2): 451-462.e2, 2017 02.
Article in En | MEDLINE | ID: mdl-27769809
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications / Congenital Abnormalities / Biological Products / Inflammatory Bowel Diseases / Glucocorticoids / Aminosalicylic Acids / Immunologic Factors / Anti-Bacterial Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Country/Region as subject: America do norte Language: En Journal: Gastroenterology Year: 2017 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications / Congenital Abnormalities / Biological Products / Inflammatory Bowel Diseases / Glucocorticoids / Aminosalicylic Acids / Immunologic Factors / Anti-Bacterial Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Country/Region as subject: America do norte Language: En Journal: Gastroenterology Year: 2017 Document type: Article Country of publication: United States